Tuesday, August 11, 2020 3:02:17 PM
Wow!! Read this folks, hoping for better results than Remdesivir.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157540209
Potentially good for the entire planet.
$RLFTF
Imho only
“We hope that Aviptadil delivers better results than Remdesivir.” Gilead's drug is the first and so far only in a scientific study to have a positive effect on disease progression and has received emergency approval.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157540209
Potentially good for the entire planet.
$RLFTF
Imho only
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
